Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience-Reference-Cited by-同舟云学术

Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience

Published:2022-08 Issue:8 Volume:22 Page:e815-e825
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Kuhlman Justin J.^ORCID,Moustafa Muhamad Alhaj^ORCID,Jiang Liuyan,Iqbal Madiha,Seegobin Karan^ORCID,Wolcott Zoe,Ayala Ernesto,Ansell Steve,Rosenthal Allison,Paludo Jonas^ORCID,Micallef Ivana,Johnston Patrick,Inwards David,Habermann Thomas,Kharfan-Dabaja Mohamed^ORCID,Witzig Thomas E.,Nowakowski Grzegorz S.,Tun Han W.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference47 articles.

1. WHO classification of tumours of haematopoietic and lymphoid tissues (Revised 4th edition);Swerdlow;IARC: Lyon,2017

2. Leukemic presentation of high-grade B cell lymphoma with MYC and BCL2 rearrangement—a series of two cases and review of literature;Shahid;J Hematopathol,2019

3. A leukemic presentation of a “triple-hit” lymphoma;Chen;Blood, The J Am Soc Hematol,2014

4. BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase;Zou;BMC Med Genetics,2017

5. Non-H odgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the N ational C ancer D ata B ase from 1998 to 2011;Al-Hamadani;Am J Hematol,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version;Annals of Hematology;2023-04-28

2. Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes;Journal of Blood Medicine;2022-11